Aspire Biopharma Holdings Inc
ASBP
Company Profile
Business description
Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.
Contact
23150 Fashion Drive
Suite 232
EsteroFL33928
USAT: +1 908 987-3002
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
Stocks News & Analysis
stocks
ASX data centre share forecasts AI fuelled earnings surge
AI and cloud demand underpin bullish growth outlook
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,154.90 | 19.10 | -0.21% |
| CAC 40 | 8,301.85 | 32.65 | -0.39% |
| DAX 40 | 25,970.11 | 288.00 | -1.10% |
| Dow JONES (US) | 52,766.88 | 419.02 | -0.79% |
| FTSE 100 | 10,789.28 | 34.98 | -0.32% |
| HKSE | 25,013.28 | 316.45 | -1.25% |
| NASDAQ | 26,099.77 | 271.12 | -1.03% |
| Nikkei 225 | 64,473.16 | 1,742.18 | -2.63% |
| NZX 50 Index | 13,813.85 | 26.95 | 0.20% |
| S&P 500 | 7,631.47 | 54.67 | -0.71% |
| S&P/ASX 200 | 8,971.90 | 8.30 | -0.09% |
| SSE Composite Index | 3,935.61 | 44.27 | -1.11% |